3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Neoplasms
7
Motor Activity
5
Rectal Neoplasms
3
Pain, Postoperative
3
Vomiting
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nausea
2
Lung Neoplasms
2
Liver Diseases
2
Leukemia, Myeloid, Acute
2
Fatigue
2
Colorectal Neoplasms
2
Agnosia
2
Uterine Cervical Neoplasms
1
Ulcer
1
Stomatitis
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Postoperative Cognitive Complications
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Pediatric Brain Tumor
1
Pathologic Processes
1
Papillomavirus Infections
1
Pain
1
Osteolysis
1
Multiple Myeloma
1
Malnutrition
1
Interventions
Magnetic Resonance Spectroscopy
10
trametinib
7
Nivolumab
7
selpercatinib
6
pembrolizumab
6
dabrafenib
6
Iodine-131
6
Specimen Handling
5
Biopsy
5
lenvatinib
4
Vemurafenib
4
Iodine-124
4
durvalumab
3
cabozantinib
3
binimetinib
3
Ipilimumab
3
Immunoglobulin G
3
Fluorodeoxyglucose F18
3
Disulfides
3
Cyclophosphamide
3
Cetuximab
3
vandetanib
2
ulixertinib
2
omipalisib
2
larotrectinib
2
defactinib
2
copanlisib
2
cemiplimab
2
anlotinib
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Control Groups
×
1 year
×
Clear all
No trials found.